291 related articles for article (PubMed ID: 1318197)
21. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
22. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.
Dollard SC; Broker TR; Chow LT
J Virol; 1993 Mar; 67(3):1721-6. PubMed ID: 8382318
[TBL] [Abstract][Full Text] [Related]
24. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M; Dong XP; Beyer-Finkler E; Stubenrauch F; Fuchs PG; Pfister H
EMBO J; 1994 Mar; 13(6):1460-6. PubMed ID: 8137827
[TBL] [Abstract][Full Text] [Related]
25. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
26. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.
Desaintes C; Hallez S; Van Alphen P; Burny A
J Virol; 1992 Jan; 66(1):325-33. PubMed ID: 1309249
[TBL] [Abstract][Full Text] [Related]
28. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.
Sedman SA; Barbosa MS; Vass WC; Hubbert NL; Haas JA; Lowy DR; Schiller JT
J Virol; 1991 Sep; 65(9):4860-6. PubMed ID: 1651408
[TBL] [Abstract][Full Text] [Related]
29. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
30. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
Ai W; Narahari J; Roman A
J Virol; 2000 Jun; 74(11):5198-205. PubMed ID: 10799595
[TBL] [Abstract][Full Text] [Related]
31. Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.
Dooley KE; Warburton A; McBride AA
mBio; 2016 Sep; 7(5):. PubMed ID: 27624132
[TBL] [Abstract][Full Text] [Related]
32. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
33. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
34. Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events.
Sang BC; Barbosa MS
Virology; 1992 Aug; 189(2):448-55. PubMed ID: 1641976
[TBL] [Abstract][Full Text] [Related]
35. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.
Yukawa K; Butz K; Yasui T; Kikutani H; Hoppe-Seyler F
J Virol; 1996 Jan; 70(1):10-6. PubMed ID: 8523512
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
Lechner MS; Mack DH; Finicle AB; Crook T; Vousden KH; Laimins LA
EMBO J; 1992 Aug; 11(8):3045-52. PubMed ID: 1379175
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
38. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
[TBL] [Abstract][Full Text] [Related]
39. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China.
Stephen AL; Thompson CH; Tattersall MH; Cossart YE; Rose BR
Int J Cancer; 2000 Jun; 86(5):695-701. PubMed ID: 10797293
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
